Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors

Archive ouverte

Pearson, Andrew Dj. | Allen, Carl | Fangusaro, Jason | Hutter, Caroline | Witt, Olaf | Weiner, Susan | Reaman, Gregory | Russo, Mark | Bandopadhayay, Pratiti | Ahsan, Sama | Barone, Amy | Barry, Elly | de Rojas, Teresa | Fisher, Michael | Fox, Elizabeth | Bender, Julia Glade | Gore, Lia | Hargrave, Darren | Hawkins, Doug | Kreider, Brent | Langseth, Abraham | Lesa, Giovanni | Ligas, Franca | Marotti, Marcelo | Marshall, Lynley | Nasri, Kahina | Norga, Koen | Nysom, Karsten | Pappo, Alberto | Rossato, Gianluca | Scobie, Nicole | Smith, Malcolm | Stieglitz, Elliot | Weigel, Brenda | Weinstein, Amy | Viana, Ruth | Karres, Dominik | Vassal, Gilles

Edité par CCSD ; Elsevier -

International audience. Background: In developed countries, cancer remains the leading cause of pediatric death from illness after the neonatal period. Objective: To describe the end-of-life care characteristics of children and adolescents with solid tumors (ST) or hematologic malignancies (HM) who died from tumor progression in the Île-de-France area. Methods: This is a regional, multicentric, retrospective review of medical files of all children and adolescents with cancer who died over a 1-year period. Extensive data from the last 3 months of life were collected. Results: A total of 99 eligible patients died at a median age of 9.8 years (range, 0.3–24 years). The most frequent terminal symptoms were pain (n = 86), fatigue (n = 84), dyspnea (n = 49), and anorexia (n = 41). Median number of medications per patient was 8 (range, 3–18). Patients required administration of opioids (n = 91), oxygen (n = 36), and/or sedation (n = 61). Decision for palliative care was present in all medical records and do-not-resuscitate orders in 90/99 cases. Symptom prevalence was comparable between children and adolescents with ST and HM. A wish regarding the place of death had been expressed for 64 patients and could be respected in 42 cases. Death occurred in hospital for 75 patients. Conclusions: This study represents a large and informative cohort illustrating current pediatric palliative care approaches in pediatric oncology. End-of-life remains an active period of care requiring coordination of multiple care teams.

Consulter en ligne

Suggestions

Du même auteur

Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies

Archive ouverte | Pearson, Andrew D.J. | CCSD

International audience

Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas

Archive ouverte | Pearson, Andrew Dj. | CCSD

International audience

ACCELERATE – Five years accelerating cancer drug development for children and adolescents

Archive ouverte | Pearson, Andrew D.J. | CCSD

International audience. Rapid evaluation and subsequent regulatory approval of new drugs are critical to improving survival and reducing long-term side-effects for children and adolescents with cancer. The internati...

Chargement des enrichissements...